Grade My Investments
HomeFree Stock Grades › UTMD

Utah Medical Products, Inc. (UTMD) Stock Grade

UTMD · Healthcare

B
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$185.2M
P/E Ratio
16.4
Revenue Growth (YoY)
-5.8%
Net Margin
29.3%
Return on Equity
9.5%
Dividend Yield
2.1%

About Utah Medical Products, Inc.'s fundamentals

Utah Medical Products is a small-cap medical devices company with a market capitalization of $185.2 million, currently trading at a P/E ratio of 16.4. The company maintains a notably strong net profit margin of 29.3%, indicating efficient cost management and pricing power in its niche market. However, revenue has declined 5.8% year-over-year, suggesting headwinds in sales performance. With a return on equity of 9.5% and a dividend yield of 2.1%, the company returns modest capital to shareholders while generating below-average returns on reinvested earnings.

Track UTMD free — no credit card required. Live grade + monthly AI report →